![Ryan Zeidan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Zeidan currently works at Sling Therapeutics, Inc., as President, Chief Executive Officer & Director.
Dr. Zeidan also formerly worked at Millendo Therapeutics, Inc., as Chief Development Officer from 2019 to 2021.
Dr. Zeidan received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from California Institute of Technology.
| Sociétés | Poste | Début |
|---|---|---|
Sling Therapeutics, Inc.
 Sling Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapy for thyroid eye disease | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| MILLENDO THERAPEUTICS | Corporate Officer/Principal | 29/01/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapy for thyroid eye disease | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
